Medical Eligibility Required Semaglutide and Tirzepatide cannot be prescribed to individuals with the following conditions: BMI under 27, eating disorders, Type 1 diabetes, gallbladder disease, substance abuse, recent bariatric surgery (within the past 6 months), pancreatitis or history of recurrent pancreatitis while taking a GLP-1 medication, medullary thyroid cancer, current pregnancy or breastfeeding, plans to become pregnant, diabetic retinopathy, multiple endocrine neoplasia type 2 (MEN2) or family history of MEN2, serious gastrointestinal disorders, or history of allergic reaction to Tirzepatide or Semaglutide
PeterMD operates two support lines: new patients can call or text 772-800-6133 Monday through Sunday, 7 a.m
Dont skip your injection day
With the right knowledge and proactive management, the benefits of semaglutide can be maximized while minimizing potential risks
doi: 10.2174/0125899775370658250713030329 94 NazerianY.GhasemiM.YassaghiY.NazerianA.HashemiS